Announcements Trials
Browse Landscape

Phase

Phase 2 63Phase 3 56Phase 1 17Phase 1/2 8Phase 4 5Phase 2/3 5Phase NA 4Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 3Head & Neck 1

Conditions

Urinary Bladder Neoplasms 2Recurrence 1Non-Muscle Invasive Bladder Neoplasms 1Head and Neck Neoplasms 1Conjunctival Intraepithelial Neoplasia 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Mitomycin × Clear all
NCT03348969 2026-03-03

NICSA

Aarhus University Hospital

Phase 4 Completed
120 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06781879 2025-10-03

COBRA-NMIBC

Aarhus University Hospital

Phase 4 Recruiting
272 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT02015650 2020-05-18

Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck

Medical University Innsbruck

Phase 4 Terminated
4 enrolled
Head & Neck

Head and Neck Neoplasms

NCT03790384 2018-12-31

MITOBCG

Azienda Ospedaliera "Sant'Andrea"

Phase 4 Unknown
140 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02199327 2017-08-08

Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia

Coordinación de Investigación en Salud, Mexico

Phase 4 Completed
18 enrolled

Conjunctival Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡